Oral treatment with uracil-tegafur, etoposide and leucovorin in non-Asian patients with recurrent non-small cell lung cancer: A non-randomized, phase II study

被引：0
|
作者：
Surmont, V. F.
Aerts, J.
Pouw, E.
Vernhout, R. M.
Gras, E. J.
Tan, K. Y.
Hoogsteden, H.
van Klaveren, R.
机构：
[1] Dr Daniel Den Hoed Canc Ctr, NL-3008 AE Rotterdam, Netherlands
[2] Amphia Hosp, Breda, Netherlands
[3] Groene Hartziekenhuis, Gouda, Netherlands
[4] St Franciscus Gasthuis, Rotterdam, Netherlands
[5] Erasmus MC, Rotterdam, Netherlands
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19019
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19019
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II randomized study comparing the toxicity profile of gemcitabine plus cisplatin with gemcitabine plus oral etoposide in the treatment of advanced non-small cell lung cancer
    Mok, TSK
    Lam, KC
    Lee, C
    Zhang, L
    Wong, H
    Chan, ATC
    Yeo, W
    Yim, APC
    Chak, K
    Zee, B
    ONCOLOGY, 2005, 68 (4-6) : 485 - 492
  • [32] Ethnic Difference in Hematological Toxicity in Patients with Non-small Cell Lung Cancer Treated with Chemotherapy A Pooled Analysis on Asian versus Non-Asian in Phase II and III Clinical Trials
    Hasegawa, Yoshikazu
    Kawaguchi, Tomoya
    Kubo, Akihito
    Ando, Masahiko
    Shiraishi, Junji
    Isa, Shun-ichi
    Tsuji, Taisuke
    Tsujino, Kazuyuki
    Ou, Sai-Hong I.
    Nakagawa, Kazuhiko
    Takada, Minoru
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1881 - 1888
  • [33] Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101)
    Masafumi Yamaguchi
    Hirohito Tada
    Tetsuya Mitsudomi
    Takashi Seto
    Kohei Yokoi
    Nobuyuki Katakami
    Kazuhiko Nakagawa
    Makoto Oda
    Mitsunori Ohta
    Toshiyuki Sawa
    Motohiro Yamashita
    Norihiko Iked
    Hideo Saka
    Masahiko Higashiyama
    Hiroaki Nomori
    Hiroshi Semba
    Shunichi Negoro
    Yasutaka Chiba
    Mototsugu Shimokawa
    Masahiro Fukuoka
    Yoichi Nakanishi
    International Journal of Clinical Oncology, 2021, 26 : 2216 - 2223
  • [34] Activity of gemcitabine in the treatment of patients with non-small cell lung cancer: a multicenter phase II study
    Yokoyama, A
    Nakai, Y
    Yoneda, S
    Kurita, Y
    Niitani, H
    ANTI-CANCER DRUGS, 1997, 8 (06) : 574 - 581
  • [35] Phase II study of uracil-tegafur with leucovorin in elderly (≥ 75 years old) patients with colorectal cancer:: ECOG 1299
    Hochster, Howard S.
    Luo, Weixiu
    Popa, Elizabeta C.
    Lyman, Bruce T.
    Mulcahy, Mary
    Beatty, Peter A.
    Benson, Al Bowen
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (34) : 5397 - 5402
  • [36] A phase II study of cisplatin, 5-fluorouracil, leucovorin, and etoposide in advanced non-small-cell lung cancer
    Rixe, O
    Coeffic, D
    Orcel, B
    Maitre, B
    Borel, C
    Benhammouda, A
    Petit, T
    Khayat, D
    Derenne, JP
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (02): : 128 - 131
  • [37] A phase II study of vinorelbine in patients with advanced non-small cell lung cancer
    Evans, TRJ
    Mansi, JL
    Morgan, DAL
    Gyi, KM
    Banham, SW
    Milroy, R
    ONCOLOGY REPORTS, 1997, 4 (06) : 1337 - 1341
  • [38] PHASE II STUDY OF VINDESINE IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    FUJITA, J
    SAIJO, N
    EGUCHI, K
    SHINKAI, T
    TOMINAGA, K
    SASAKI, Y
    FUTAMI, H
    SAKURAI, M
    ISHIHARA, J
    TAKAHASHI, H
    HOSHI, A
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (09): : 902 - 905
  • [39] Phase II study of paclitaxel and cisplatin in patients with non-small cell lung cancer
    vonPawel, J
    Wagner, H
    Niederle, N
    Heider, A
    Koschel, G
    Hecker, D
    Hanske, M
    SEMINARS IN ONCOLOGY, 1996, 23 (06) : 47 - 50
  • [40] Phase II study of dasatinib in patients with advanced non-small cell lung cancer
    Johnson, F. M.
    Bekele, B. N.
    Feng, L.
    Wistuba, I. I.
    Tang, X.
    Tran, H. T.
    Erasmus, J. J.
    Hwang, L.
    Takebe, N.
    Stewart, D. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345